FDA Inspection
Carnegie Pharmaceutical LlcCarnegie Pharmaceutical Llc – FDA Inspection, Jul 7, 2023
Record Details
This FDA Inspection record concerns Carnegie Pharmaceutical Llc, with an inspection on July 7, 2023, issued by the New Jersey District Office.
- Company
- Carnegie Pharmaceutical Llc
- Inspection Date
- July 7, 2023
View Company Profile
ID · 340962b6-09c6-4716-b1d7-ca98960f2af6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1209581
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carnegie Pharmaceutical Llc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 19, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Carnegie Pharmaceutical Llc
- FDA Inspection 1292782 - 2025-10-31
- FDA Inspection 1158525 - 2021-11-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.